Delivery Order SPE2DB20D7066-SPE2DB25FC4RD
Award Date 9/9/25
Potential Completion Date 9/10/25
Potential Value $2.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,993.45 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Adenosine 12 mg/4 ml syringes. The contract, which is not set-aside and competitively awarded, represents a firm fixed price delivery order with an ultimate completion date of August 26, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Adenosine 12 mg/4 mL syringes with a ceiling value of $1,183.83. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13,...
- The Defense Logistics Agency awarded a delivery order valued at $1,292.82 to AmerisourceBergen Drug Corp for the supply of Adenosine 12 mg/4 mL syringes on August 21, 2025, with completion scheduled for August 22, 2025. This contract, which carries no set-aside designation, was competitively awarded on a firm fixed-price basis and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of pharmaceutical supply support under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Adenosine 12 mg/4 ml syringes with a ceiling value of $2,264.34. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Adenosine 12 mg/4 mL syringes with a ceiling value of $1,027.81. This non-competitive delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. The contract utilizes firm fixed pricing under a delivery order arrangement, representing a...
- The Defense Logistics Agency awarded a delivery order valued at $3,091.99 to AmerisourceBergen Drug Corp for the supply of Adenosine 12 mg/4 mL syringes on August 22, 2025, with completion expected by August 25, 2025. This firm fixed-price delivery order is being fulfilled from the company's place of performance in Conshohocken, Pennsylvania, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Adenosine Injection with a ceiling value of $4,667.56. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 9, 2025, and represents a small-value pharmaceutical transaction typical of the agency's medical procurement operations. The order will be fulfilled from AmerisourceBergen's Corporate...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Adenosine 12 mg/4 mL vials with a ceiling value of $1,084.19. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and no set-aside designation was used in the award. The work will be performed at the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Adenosine Injection with a ceiling value of $1,425.10 under firm fixed-price terms. The contract, which was competitively awarded without set-aside provisions, is effective through August 23, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $1,136.88 delivery order to AmerisourceBergen Drug Corp for the supply of Adenosine 12 mg/4 mL vials on July 18, 2025, with completion targeted for July 21, 2025. The award utilizes firm fixed pricing with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...